Highbridge Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Highbridge Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-13,611	Closed	-$37K	–	1848
2016 Q3	$37K	Buy	+13,611	New	+$34.6K	﹤0.01%	1264
2016 Q1	–	Sell	-125,777	Closed	-$603K	–	2125
2015 Q4	$603K	Buy	+125,777	New	+$713K	0.01%	937
2015 Q1	–	Sell	-10,110	Closed	-$121K	–	1793
2014 Q4	$121K	Buy	+10,110	New	+$154K	﹤0.01%	1101
2014 Q1	–	Sell	-34,683	Closed	-$205K	–	1444
2013 Q4	$205K	Buy	+34,683	New	+$179K	﹤0.01%	969

Other funds holding BDSI

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return

Highbridge Capital Management's BDSI Position: Q4 2016 in Review

Highbridge Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2016, closing a stake of 13,611 shares — an estimated $37K sold.

Highbridge Capital Management first reported a position in BDSI in Q4 2013 and held it in 4 quarters. The position peaked at $603K in Q4 2015. 77 funds tracked by Wall St. Rank hold BDSI as of Q4 2016.

Highbridge Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2016 after selling out during the quarter.
Highbridge Capital Management sold 13,611 BioDelivery Sciences International, Inc. shares in Q4 2016, an estimated $37K.
Highbridge Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q4 2013 and held it in 4 quarters.
Highbridge Capital Management's BioDelivery Sciences International, Inc. position peaked at $603K in Q4 2015.
77 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2016.

Based on Highbridge Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.